Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles
- PMID: 22865900
- PMCID: PMC3462940
- DOI: 10.1210/jc.2012-1738
Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles
Abstract
Context: A high chromosomal abnormalities rate has been observed in human embryos derived from in vitro fertilization (IVF) treatments. The real incidence in natural cycles has been poorly studied, so whether this frequency may be induced by external factors, such as use of gonadotropins for ovarian stimulation, remains unknown.
Design: We conducted a prospective cohort study in a University-affiliated private infertility clinic with a comparison between unstimulated and stimulated ovarian cycles in the same women. Preimplantation genetic screening by fluorescence in situ hybridization was performed in all viable d 3 embryos.
Objective: The primary objective was to compare the incidence of embryo chromosomal abnormalities in an unstimulated cycle and in an ulterior moderate ovarian stimulated cycle. Secondary outcome measures were embryo quality, blastocyst rate of biopsied embryos, number of normal blastocysts per donor, type of chromosomal abnormalities, and clinical outcome.
Results: One hundred eighty-five oocyte donors were initially recruited for the unstimulated cycle, and preimplantation genetic screening could be performed in 51 of them, showing 35.3% of embryo chromosomal abnormalities. Forty-six of them later completed a stimulated cycle. The sperm donor sample was the same for both cycles. The proportion of embryos displaying abnormalities in the unstimulated cycle was 34.8% (16 of 46), whereas it was 40.6% (123 of 303) in the stimulated cycle with risk difference=5.8 [95% confidence interval (CI)=-20.6-9.0], and relative risk=1.17 (95% CI=0.77-1.77) (P=0.45). When an intrasubject comparison was made, the abnormalities rate was 34.8% (95% CI=20.5-49.1) in the unstimulated cycle and 38.2% (95% CI=30.5-45.8) in the stimulated cycle [risk difference=3.4 (95% CI=-17.9-11.2); P=0.64]. No differences were observed for embryo quality and type of chromosomal abnormalities.
Conclusions: Moderate ovarian stimulation in young normo-ovulatory women does not significantly increase the embryo aneuploidies rate in in vitro fertilization-derived human embryos as compared with an unstimulated cycle. Whether these results can be extrapolated to infertile patients is still unknown.
Trial registration: ClinicalTrials.gov NCT00707525.
Figures



Similar articles
-
Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.Fertil Steril. 2016 Aug;106(2):334-341.e1. doi: 10.1016/j.fertnstert.2016.04.006. Epub 2016 Apr 22. Fertil Steril. 2016. PMID: 27114329
-
Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle.Hum Reprod. 2018 Aug 1;33(8):1442-1448. doi: 10.1093/humrep/dey217. Hum Reprod. 2018. PMID: 29912374 Free PMC article.
-
Double-edged sword: effects of human sperm reactive oxygen species on embryo development in IVF cycles.Reprod Biol Endocrinol. 2023 Jan 4;21(1):1. doi: 10.1186/s12958-022-01053-7. Reprod Biol Endocrinol. 2023. PMID: 36600238 Free PMC article.
-
Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis.Hum Reprod. 2019 Mar 1;34(3):491-505. doi: 10.1093/humrep/dey388. Hum Reprod. 2019. PMID: 30689865
-
Regimen of ovarian stimulation affects oocyte and therefore embryo quality.Fertil Steril. 2016 Mar;105(3):560-570. doi: 10.1016/j.fertnstert.2016.01.022. Epub 2016 Jan 27. Fertil Steril. 2016. PMID: 26826273 Review.
Cited by
-
Mosaicism in Preimplantation Human Embryos: When Chromosomal Abnormalities Are the Norm.Trends Genet. 2017 Jul;33(7):448-463. doi: 10.1016/j.tig.2017.04.001. Epub 2017 Apr 28. Trends Genet. 2017. PMID: 28457629 Free PMC article. Review.
-
Individualized controlled ovarian stimulation in expected poor-responders: an update.Reprod Biol Endocrinol. 2018 Mar 9;16(1):20. doi: 10.1186/s12958-018-0342-1. Reprod Biol Endocrinol. 2018. PMID: 29523204 Free PMC article. Review.
-
Chromosomal Aneuploidies and Early Embryonic Developmental Arrest.Int J Fertil Steril. 2015 Oct-Dec;9(3):346-53. doi: 10.22074/ijfs.2015.4550. Epub 2015 Oct 31. Int J Fertil Steril. 2015. PMID: 26644858 Free PMC article.
-
Best practices for controlled ovarian stimulation in in vitro fertilization.Semin Reprod Med. 2015 Mar;33(2):77-82. doi: 10.1055/s-0035-1546424. Epub 2015 Mar 3. Semin Reprod Med. 2015. PMID: 25734345 Free PMC article. Review.
-
"Short agonist stop" protocol, an ovarian stimulation for poor responders in in vitro fertilization (IVF): A pilot study.Front Endocrinol (Lausanne). 2022 Nov 17;13:1056520. doi: 10.3389/fendo.2022.1056520. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36465628 Free PMC article.
References
-
- Nygren KG, Sullivan E, Zegers-Hochschild F, Mansour R, Ishihara O, Adamson GD, de Mouzon J. 2011. International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003. Fertil Steril 95:2209–2222, 2222.e1–e17 - PubMed
-
- Hansen M, Kurinczuk JJ, Bower C, Webb S. 2002. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med 346:725–730 - PubMed
-
- Olson CK, Keppler-Noreuil KM, Romitti PA, Budelier WT, Ryan G, Sparks AE, Van Voorhis BJ. 2005. In vitro fertilization is associated with an increase in major birth defects. Fertil Steril 84:1308–1315 - PubMed
-
- Wells D, Delhanty JD. 2000. Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. Mol Hum Reprod 6:1055–1062 - PubMed
-
- Plachot M, Veiga A, Montagut J, de Grouchy J, Calderon G, Lepretre S, Junca AM, Santalo J, Carles E, Mandelbaum J, et al. 1988. Are clinical and biological IVF parameters correlated with chromosomal disorders in early life: a multicentric study. Hum Reprod 3:627–635 - PubMed